These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17097145)

  • 1. Synthesis and characterization of new beta-diketo derivatives with iron chelating ability.
    Benassi R; Ferrari E; Grandi R; Lazzari S; Saladini M
    J Inorg Biochem; 2007 Feb; 101(2):203-13. PubMed ID: 17097145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency.
    Ferrari E; Arezzini B; Ferrali M; Lazzari S; Pignedoli F; Spagnolo F; Saladini M
    Biometals; 2009 Oct; 22(5):701-10. PubMed ID: 19205899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron(III) complexing ability of carbohydrate derivatives.
    Ferrari E; Saladini M
    J Inorg Biochem; 2004 Jun; 98(6):1002-8. PubMed ID: 15149808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2006; 84(5):472-89. PubMed ID: 16705688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 2-methyl-3-hydroxy-4-pyridinecarboxylic acid as a possible chelating agent for iron and aluminium.
    Dean A; Ferlin MG; Brun P; Castagliuolo I; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
    Dalton Trans; 2008 Apr; (13):1689-97. PubMed ID: 18354766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
    Bernhardt PV; Chin P; Richardson DR
    J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, chemical and biological studies on new Fe(3+)-glycosilated beta-diketo complexes for the treatment of iron deficiency.
    Arezzini B; Ferrali M; Ferrari E; Frassineti C; Lazzari S; Marverti G; Spagnolo F; Saladini M
    Eur J Med Chem; 2008 Nov; 43(11):2549-56. PubMed ID: 18439726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III).
    Nurchi VM; Lachowicz JI; Crisponi G; Murgia S; Arca M; Pintus A; Gans P; Niclos-Gutierrez J; Domínguez-Martín A; Castineiras A; Remelli M; Szewczuk Z; Lis T
    Dalton Trans; 2011 Jun; 40(22):5984-98. PubMed ID: 21552634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
    Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
    J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the aqueous iron(III) chelation chemistry of a potential Trojan Horse antimicrobial agent: chelate structure, stability and pH dependent speciation.
    Harrington JM; Gootz T; Flanagan M; Lall M; O'Donnell J; Winton J; Mueller J; Crumbliss AL
    Biometals; 2012 Oct; 25(5):1023-36. PubMed ID: 22855208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation properties of an extracellular siderophore exochelin MN.
    Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
    J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,6-Dimethyl-4-hydroxy-3-pyridinecarboxylic acid and 4-hydroxy-2-methyl-3-pyridinecarboxylic acid as new possible chelating agents for iron and aluminium.
    Dean A; Ferlin MG; Brun P; Castagliuolo I; Yokel RA; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
    Dalton Trans; 2009 Mar; (10):1815-24. PubMed ID: 19240917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
    Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
    J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity.
    Bernhardt PV; Sharpe PC; Islam M; Lovejoy DB; Kalinowski DS; Richardson DR
    J Med Chem; 2009 Jan; 52(2):407-15. PubMed ID: 19090766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron chelation properties of an extracellular siderophore exochelin MS.
    Dhungana S; Ratledge C; Crumbliss AL
    Inorg Chem; 2004 Oct; 43(20):6274-83. PubMed ID: 15446873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family of hydroxypyrone ligands designed and synthesized as iron chelators.
    Toso L; Crisponi G; Nurchi VM; Crespo-Alonso M; Lachowicz JI; Santos MA; Marques SM; Niclós-Gutiérrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z
    J Inorg Biochem; 2013 Oct; 127():220-31. PubMed ID: 23859830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of the tetranuclear iron(III) complex of a new asymmetric multidentate ligand. A structural model for purple acid phosphatases.
    Boudalis AK; Aston RE; Smith SJ; Mirams RE; Riley MJ; Schenk G; Blackman AG; Hanton LR; Gahan LR
    Dalton Trans; 2007 Nov; (44):5132-9. PubMed ID: 17985020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-2-(5-hydroxypentyl)-4H-chromen-4-one: a bidentate or tridentate iron(III) ligand?
    Kong X; Zhou T; Neubert H; Liu Z; Hider RC
    J Med Chem; 2006 May; 49(10):3028-31. PubMed ID: 16686545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.